Chimeric Antigen Receptor (CAR)-Modified T Cells (CTL019) Induce Durable CNS Remissions in Children with CNS/Combined Bone Marrow and CNS Relapsed/Refractory CD19+Acute Lymphoblastic Leukemia

被引：0

作者：

Talekar, Mala ^{[1
]}

Hucks, George ^{[1
]}

Maude, Shannon ^{[1
]}

Kawchak, Nicholas ^{[1
]}

Motley, Laura ^{[1
]}

Barrett, David ^{[1
]}

Lacey, Simon ^{[1
]}

Levine, Bruce ^{[1
]}

Melenhorst, Jan ^{[1
]}

Shaw, Pamela ^{[1
]}

Callahan, Colleen ^{[1
]}

White, Claire ^{[1
]}

Barker, Christine ^{[1
]}

Baniewicz, Diane ^{[1
]}

Duckworth, Mark ^{[1
]}

Aplenc, Richard ^{[1
]}

Teachey, David ^{[1
]}

June, Carl ^{[1
]}

Grupp, Stephan ^{[1
]}

Rheingold, Susan ^{[1
]}

机构：

[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

来源：

PEDIATRIC BLOOD & CANCER | 2017年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4005

引用

页码：S2 / S2

页数：1

共 50 条

[1] Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS/Combined Relapsed/Refractory ALL
Rheingold, Susan R.
Chen, Lanyi Nora
Maude, Shannon L.
Aplenc, Richard
Barker, Christine
Barrett, David M.
Callahan, Colleen
Cebry, Katherine
Kulikovskaya, Irina
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, Jan J.
Shaw, Pamela A.
Sparrow, Anna
Teachey, David T.
Duckworth, Mark
June, Carl H.
Grupp, Stephan A.
BLOOD, 2015, 126 (23)
[2] Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)
Grupp, Stephan A.
Maude, Shannon L.
Shaw, Pamela A.
Aplenc, Richard
Barrett, David M.
Callahan, Colleen
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, J. Joseph
Motley, Laura
Rheingold, Susan R.
Teachey, David T.
Wood, Patricia A.
Porter, David
June, Carl H.
BLOOD, 2015, 126 (23)
[3] T Cells Engineered with a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL
Grupp, Stephan A.
Maude, Shannon L.
Shaw, Pamela
Aplenc, Richard
Barrett, David M.
Callahan, Colleen
Chew, Anne
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, J. Joseph
Motley, Laura
Rheingold, Susan R.
Shen, Angela
Teachey, David T.
Wood, Patricia A.
Porter, David L.
June, Carl H.
BLOOD, 2014, 124 (21)
[4] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
Newman, Haley
Leahy, Allison Emily Barz
Li, Yimei
Liu, Hongyan
Myers, Regina M.
DiNofia, Amanda M.
Dolan, Joseph Gregory
Callahan, Colleen
Devine, Kaitlin J.
Wray, Lisa
June, Carl H.
Grupp, Stephan A.
Rheingold, Susan R.
Maude, Shannon L.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS INDUCE DURABLE REMISSIONS IN CHILDREN WITH RELAPSED/REFRACTORY ALL
Maude, Shannon
Shaw, Pamela
Aplenc, Richard
Barrett, David
Barker, Christine
Callahan, Colleen
Lacey, Simon
Levine, Bruce
Melenhorst, Jan
Motley, Laura
Rheingold, Susan
Teachev, David
June, Carl
Grupp, Stephan
PEDIATRIC BLOOD & CANCER, 2015, 62 : 21 - 21
[6] Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+acute lymphoblastic leukemia (ALL).
Talekar, Mala Kiran
Maude, Shannon L.
Hucks, George E.
Motley, Laura S.
Callahan, Colleen
White, Claire M.
Baniewicz, Diane
Barrett, David Maxwell
Rheingold, Susan R.
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, Jan J.
Teachey, David T.
June, Carl H.
Grupp, Stephan A.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7] Cellular Kinetics of Chimeric Antigen Receptor T Cells (CTL019) in Patients with Relapsed/Refractory CD19+Leukemia
Mueller, Karen Thudium
Chakraborty, Abhijit
Wood, Patricia A.
Awasthi, Rakesh
Quintas-Cardama, Alfonso
Han, Xia
Maude, Shannon L.
Grupp, Stephan A.
Porter, David L.
Frey, Noelle
Marcucci, Katherine T.
Levine, Bruce L.
Melenhorst, Jan J.
June, Carl H.
Lacey, Simon F.
BLOOD, 2016, 128 (22)
[8] Sustained Remissions Following Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+Lymphomas
Schuster, Stephen J.
Svoboda, Jakub
Nasta, Sunita Dwivedy
Porter, David L.
Chong, Elise A.
Landsburg, Daniel J.
Mato, Anthony R.
Lacey, Simon F.
Melenhorst, Jan J.
Chew, Anne
Hasskarl, Jens
Shah, Gaurav D.
Wasik, Mariusz A.
Marcucci, Katherine T.
Zheng, Zhaohui
Levine, Bruce L.
June, Carl H.
BLOOD, 2015, 126 (23)
[9] CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS DIRECTED AGAINST CD19 (CTL019) INDUCE CLINICAL RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY CD19+LYMPHOMAS
Levine, B.
Svoboda, J.
Nasta, S. D.
Porter, D.
Chong, E.
Lacey, S.
Mahnke, Y.
Melenhorst, J.
Chew, A.
Shah, G.
Hasskar, J.
Wasik, M.
Landsburg, D.
Mato, A.
Garfall, A.
Frey, N.
Shaw, P.
Marcucci, K.
Shea, J.
McConville, H.
Manvar, N.
O'Rourke, M.
Lamontagne, A.
Bersenev, A.
Zheng, Z.
Schuster, S.
June, C.
CYTOTHERAPY, 2015, 17 (06) : S13 - S13
[10] DURABLE REMISSIONS WITH CONTROL OF CYTOKINE RELEASE SYNDROME (CRS) USING T CELLS EXPRESSING CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) CTL019 TO TREAT RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOID LEUKEMIA (ALL)
Levine, B. L.
Maude, S.
Zheng, Z.
Shaw, P.
Ambrose, D.
Aplenc, R.
Barker, C.
Barrett, D.
Brogdon, J.
Callahan, C.
Chen, F.
Chew, A.
Davis, M. M. Suhoski
Fesnak, A. D.
Finklestein, J.
Frey, N.
Lacey, S.
Lamontagne, A.
Lewitt, L.
Loew, A.
Marcucci, K.
Melenhorst, J.
Motley, L.
Mudambi, M.
Nazimuddin, F.
O'Rourke, M.
Porter, D.
Rheingold, S. R.
Scholler, J.
Tayor, C.
White, C.
Wood, P.
Young, R.
Teachey, D. T.
June, C.
Grupp, S.
CYTOTHERAPY, 2016, 18 (06) : S14 - S15

← 1 2 3 4 5 →